Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tekla Healthcare Investors stock

Own Tekla Healthcare Investors stock in just a few minutes.

Tekla Healthcare Investors is an asset management business based in the US. Tekla Healthcare Investors shares (HQH) are listed on the NYSE and all prices are listed in US Dollars.

How to buy shares in Tekla Healthcare Investors

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HQH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Tekla Healthcare Investors share price

Use our graph to track the performance of HQH stocks over time.

Tekla Healthcare Investors shares at a glance

Information last updated 2021-04-29.
52-week range$18.00 - $25.50
50-day moving average $24.39
200-day moving average $23.34
Wall St. target priceN/A
PE ratio 4.4998
Dividend yield $1.78 (7.15%)
Earnings per share (TTM) $5.50

Buy Tekla Healthcare Investors shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tekla Healthcare Investors stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Tekla Healthcare Investors under- or over-valued?

Valuing Tekla Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tekla Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Tekla Healthcare Investors's P/E ratio

Tekla Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Tekla Healthcare Investors shares trade at around 4x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Tekla Healthcare Investors financials

Revenue TTM $8.9 million
Gross profit TTM $8.9 million
Return on assets TTM -0.13%
Return on equity TTM 25.05%
Profit margin 2700.1%
Book value $24.04
Market capitalisation $1.1 billion

TTM: trailing 12 months

Shorting Tekla Healthcare Investors shares

There are currently 77,892 Tekla Healthcare Investors shares held short by investors – that's known as Tekla Healthcare Investors's "short interest". This figure is 212% up from 24,967 last month.

There are a few different ways that this level of interest in shorting Tekla Healthcare Investors shares can be evaluated.

Tekla Healthcare Investors's "short interest ratio" (SIR)

Tekla Healthcare Investors's "short interest ratio" (SIR) is the quantity of Tekla Healthcare Investors shares currently shorted divided by the average quantity of Tekla Healthcare Investors shares traded daily (recently around 169330.43478261). Tekla Healthcare Investors's SIR currently stands at 0.46. In other words for every 100,000 Tekla Healthcare Investors shares traded daily on the market, roughly 460 shares are currently held short.

However Tekla Healthcare Investors's short interest can also be evaluated against the total number of Tekla Healthcare Investors shares, or, against the total number of tradable Tekla Healthcare Investors shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tekla Healthcare Investors's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Tekla Healthcare Investors shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Tekla Healthcare Investors shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tekla Healthcare Investors.

Find out more about how you can short Tekla Healthcare Investors stock.

Tekla Healthcare Investors's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Tekla Healthcare Investors.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Tekla Healthcare Investors's total ESG risk score

Total ESG risk: 29.97

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Tekla Healthcare Investors's overall score of 29.97 (as at 12/31/2018) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Tekla Healthcare Investors is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Tekla Healthcare Investors's environmental score

Environmental score: 3.07/100

Tekla Healthcare Investors's environmental score of 3.07 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Tekla Healthcare Investors's social score

Social score: 17.72/100

Tekla Healthcare Investors's social score of 17.72 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Tekla Healthcare Investors's governance score

Governance score: 9.07/100

Tekla Healthcare Investors's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Tekla Healthcare Investors was last rated for ESG on: 2019-01-01.

Total ESG score 29.97
Total ESG percentile 6
Environmental score 3.07
Environmental score percentile 6
Social score 17.72
Social score percentile 6
Governance score 9.07
Governance score percentile 6

Tekla Healthcare Investors share dividends

35%

Dividend payout ratio: 34.75% of net profits

Recently Tekla Healthcare Investors has paid out, on average, around 34.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.6% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tekla Healthcare Investors shareholders could enjoy a 7.6% return on their shares, in the form of dividend payments. In Tekla Healthcare Investors's case, that would currently equate to about $1.78 per share.

While Tekla Healthcare Investors's payout ratio might seem fairly standard, it's worth remembering that Tekla Healthcare Investors may be investing much of the rest of its net profits in future growth.

Tekla Healthcare Investors's most recent dividend payout was on 30 December 2018. The latest dividend was paid out to all shareholders who bought their shares by 24 February 2021 (the "ex-dividend date").

Tekla Healthcare Investors share price volatility

Over the last 12 months, Tekla Healthcare Investors's shares have ranged in value from as little as $18.0035 up to $25.4966. A popular way to gauge a stock's volatility is its "beta".

HQH.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Tekla Healthcare Investors's is 1.0094. This would suggest that Tekla Healthcare Investors's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Tekla Healthcare Investors overview

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors.

Frequently asked questions

What percentage of Tekla Healthcare Investors is owned by insiders or institutions?
Currently 0.001% of Tekla Healthcare Investors shares are held by insiders and 22.792% by institutions.
When does the fiscal year end for Tekla Healthcare Investors?
Tekla Healthcare Investors's fiscal year ends in September.
Where is Tekla Healthcare Investors based?
Tekla Healthcare Investors's address is: 100 Federal Street, Boston, MA, United States, 02110
What is Tekla Healthcare Investors's ISIN number?
Tekla Healthcare Investors's international securities identification number is: US87911J1034
What is Tekla Healthcare Investors's CUSIP number?
Tekla Healthcare Investors's Committee on Uniform Securities Identification Procedures number is: 404052102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site